Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer

Introduction: Loco regional persistence or recurrence of differentiated thyroid cancer (DTC) is frequent despite initial thyroidectomy and radioactive iodine therapy (RAI). The aim of this study was to analyze the impact of a complementary adjuvant RAI (Ad-RAI) on disease recurrence following re-ope...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Endocrinol (Lausanne)
Main Authors: Bouvet, Clément, Barres, Bertrand, Kwiatkowski, Fabrice, Batisse-Lignier, Marie, Chafai El Alaoui, Meryem, Kauffmann, Philippe, Cachin, Florent, Tauveron, Igor, Kelly, Antony, Maqdasy, Salwan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6776597/
https://ncbi.nlm.nih.gov/pubmed/31611847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00671
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados